Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios

Gut

Volumn 62, Issue 1, 2013, Pages 73-82

  Weitkamp, Jörn Hendrik ^a   Koyama, Tatsuki ^b   Rock, Michael T ^a   Correa, Hernan ^b   Goettel, Jeremy A ^b,c   Matta, Pranathi ^a   Oswald Richter, Kyra ^b   Rosen, Michael J ^a   Engelhardt, Brian G ^b   Moore, Daniel J ^a   Polk, D Brent ^a,b,d,e  

^a MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ARTICLE; CD4 CD8 RATIO; CELL ASSAY; CELL HOMING; CELL ISOLATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; IMMUNOPHENOTYPING; IMMUNOREGULATION; INFANT; LAMINA PROPRIA; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; MONONUCLEAR CELL; NECROTIZING ENTEROCOLITIS; PHENOTYPE; PREMATURITY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; TISSUE SECTION; TISSUE SPECIFICITY;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ENTEROCOLITIS, NECROTIZING; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTESTINAL MUCOSA; LYMPHOCYTE COUNT; MALE; PROSPECTIVE STUDIES; T-LYMPHOCYTES, REGULATORY;

EID: 84871162696     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-301551     Document Type: Article

References (52)

1. Fanaroff AA, Stoll BJ, Wright LL, et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 2007;196:147.e1-8.
2. Guthrie SO, Gordon PV, Thomas V, et al. Necrotizing enterocolitis among neonates in the United States. J Perinatol 2003;23:278-85. (Pubitemid 36764115)
3. Holman RC, Stoll BJ, Clarke MJ, et al. The epidemiology of necrotizing enterocolitis infant mortality in the United States. Am J Public Health 1997;87:2026-31. (Pubitemid 28055926)
4. Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet 2006;368:1271-83. (Pubitemid 44485800)
5. Hintz SR, Kendrick DE, Stoll BJ, et al. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics 2005;115:696-703. (Pubitemid 43373031)
6. Rees CM, Pierro A, Eaton S. Neurodevelopmental outcomes of neonates with medically and surgically treated necrotizing enterocolitis. Arch Dis Child Fetal Neonatal Ed 2007;92:F193-8. (Pubitemid 46698116)
7. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011;364:255-64.
8. Grave GD, Nelson SA, Walker WA, et al. New therapies and preventive approaches for necrotizing enterocolitis: report of a research planning workshop. Pediatr Res 2007;62:510-14. (Pubitemid 47476215)
9. Nanthakumar N, Meng D, Goldstein AM, et al. The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innate immune response. PLoS One 2011;6:e17776.
10. Caplan MS, Sun XM, Hseuh W, et al. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr 1990;116:960-4. (Pubitemid 20201711)
11. Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 1999; 103:766-71. (Pubitemid 29274469)
12. Kim KD, Zhao J, Auh S, et al. Adaptive immune cells temper initial innate responses. Nat Med 2007;13:1248-52. (Pubitemid 47530627)
13. Afrazi A, Sodhi CP, Richardson W, et al. New insights into the pathogenesis and treatment of necrotizing enterocolitis: toll-like receptors and beyond. Pediatr Res 2011;69:183-8.
14. Anttila A, Kauppinen H, Koivusalo A, et al. T-cell-mediated mucosal immunity is attenuated in experimental necrotizing enterocolitis. Pediatr Surg Int 2003;19:326-30. (Pubitemid 37046191)
15. Spencer J, Dillon SB, Isaacson PG, et al. T cell subclasses in fetal human ileum. Clin Exp Immunol 1986;65:553-8. (Pubitemid 16016876)
16. MacDonald TT, Spencer J. Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J Exp Med 1988;167:1341-9.
17. Wolfs TG, Buurman WA, Zoer B, et al. Endotoxin induced chorioamnionitis prevents intestinal development during gestation in fetal sheep. PLoS One 2009;4:e5837.
18. Treszl A, Tulassay T, Vasarhelyi B. Genetic basis for necrotizing enterocolitis - risk factors and their relations to genetic polymorphisms. Front Biosci 2006;11:570-80. (Pubitemid 43258164)
19. Veltkamp C, Ruhwald R, Giesem T, et al. CD4+CD25+ cell depletion from the normal CD4+ T cell pool prevents tolerance toward the intestinal flora and leads to chronic colitis in immunodeficient mice. Inflamm Bowel Dis 2006;12:437-46.
20. Moes N, Rieux-Laucat F, Begue B, et al. Reduced expression of FOXP3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy. Gastroenterology 2010;139:770-8.
21. Torgerson TR, Linane A, Moes N, et al. Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene. Gastroenterology 2007;132:1705-17. (Pubitemid 46695720)
22. Mottet C, Uhlig HH, Powrie F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 2003; 170:3939-43. (Pubitemid 36428153)
23. Luhn K, Simmons CP, Moran E, et al. Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection. J Exp Med 2007;204:979-85. (Pubitemid 46798142)
24. Agace WW. T-cell recruitment to the intestinal mucosa. Trends Immunol 2008;29:514-22.
25. Hamann A, Andrew DP, Jablonski-Westrich D, et al. Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo. J Immunol 1994;152:3282-93.
26. Schon MP, Arya A, Murphy EA, et al. Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice. J Immunol 1999;162:6641-9. (Pubitemid 29309388)
27. Fontenot JD, Dooley JL, Farr AG, et al. Developmental regulation of Foxp3 expression during ontogeny. J Exp Med 2005;202:901-6. (Pubitemid 41396890)
28. Atarashi K, Tanoue T, Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011;331:337-41.
29. Mold JE, Michaelsson J, Burt TD, et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 2008;322:1562-5.
30. Weitkamp JH, Rudzinski E, Koyama T, et al. Ontogeny of FOXP3(+) regulatory T cells in the postnatal human small intestinal and large intestinal lamina propria. Pediatr Dev Pathol 2009;12:443-9.
31. Miyara M, Sakaguchi S. Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns. Immunol Cell Biol 2011;89:346-51.
32. Alford SK, Longmore GD, Stenson WF, et al. CD46-induced immunomodulatory CD4+ T cells express the adhesion molecule and chemokine receptor pattern of intestinal T cells. J Immunol 2008;181:2544-55.
33. Bull DM, Bookman MA. Isolation and functional characterization of human intestinal mucosal lymphoid cells. J Clin Invest 1977;59:966-74. (Pubitemid 8096349)
34. Engelhardt BG, Jagasia M, Savani BN, et al. Regulatory T cell expression of CLA or alpha(4)beta(7) and skin or gut acute GVHD outcomes. Bone Marrow Transplant 2011;46:436-42.
35. Oswald-Richter KA, Beachboard DC, Zhan X, et al. Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis. Respir Res 2010;11:161.
36. Team RDC. R: A Language and Environment for Statistical Computing. Vienna, Austria, 2011. http://www.R-project.org
37. Korn T, Reddy J, Gao W, et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 2007;13:423-31. (Pubitemid 46559831)
38. Valencia X, Stephens G, Goldbach-Mansky R, et al. TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 2006;108:253-61. (Pubitemid 43990636)
39. Horwitz DA, Zheng SG, Wang J, et al. Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3+CD4+ Treg. Eur J Immunol 2008;38:912-15.
40. Deknuydt F, Bioley G, Valmori D, et al. IL-1beta and IL-2 convert human Treg into T (H)17 cells. Clin Immunol 2009;131:298-307.
41. Brusko TM, Wasserfall CH, Hulme MA, et al. Influence of membrane CD25 stability on T lymphocyte activity: implications for immunoregulation. PLoS One 2009;4:e7980.
42. Bollyky PL, Falk BA, Wu RP, et al. Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells. J Leukoc Biol 2009; 86:567-72.
43. Bollyky PL, Wu RP, Falk BA, et al. ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors. Proc Natl Acad Sci U S A 2011;108:7938-43.
44. McElroy SJ, Prince LS, Weitkamp JH, et al. Tumor necrosis factor receptor 1-dependent depletion of mucus in immature small intestine: a potential role in neonatal necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2011;4:G656-66.
45. Halpern MD, Khailova L, Molla-Hosseini D, et al. Decreased development of necrotizing enterocolitis in IL-18-deficient mice. Am J Physiol Gastrointest Liver Physiol 2008;294:G20-6.
46. Takeuchi M, Nishizaki Y, Sano O, et al. Immunohistochemical and immuno-electronmicroscopic detection of interferon-gamma-inducing factor ("interleukin-18") in mouse intestinal epithelial cells. Cell Tissue Res 1997;289:499-503. (Pubitemid 27367886)
47. Drakes ML, Blanchard TG, Czinn SJ. Colon lamina propria dendritic cells induce a proinflammatory cytokine response in lamina propria T cells in the SCID mouse model of colitis. J Leukoc Biol 2005; 78:1291-300. (Pubitemid 41779235)
48. Pender SL, Tickle SP, Docherty AJ, et al. A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol 1997;158:1582-90. (Pubitemid 127469511)
49. Pender SL, Fell JM, Chamow SM, et al. A p55 TNF receptor immunoadhesin prevents T cell-mediated intestinal injury by inhibiting matrix metalloproteinase production. J Immunol 1998;160:4098-103. (Pubitemid 28176121)
50. Gordon PV, Swanson JR, Attridge JT, et al. Emerging trends in acquired neonatal intestinal disease: is it time to abandon Bell's criteria? J Perinatol 2007;27:661-71. (Pubitemid 350020345)
51. Ivanov II, Frutos Rde L, Manel N, et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008;4:337-49.
52. Min B, Thornton A, Caucheteux SM, et al. Gut flora antigens are not important in the maintenance of regulatory T cell heterogeneity and homeostasis. Eur J Immunol 2007;37:1916-23. (Pubitemid 47065128)